Individual Patient Compassionate Use of Mirdametinib
Latest Information Update: 19 Mar 2024
At a glance
- Drugs Mirdametinib (Primary)
- Indications Neurofibromatosis 1; Tumours
- Focus Expanded access; Therapeutic Use
- Sponsors SpringWorks Therapeutics
- 06 Sep 2021 New trial record